ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Manipal Health Enterprises Investor Presentation: Key Takeaways

Manipal Health delivered robust Q1 FY27 results, with revenue growing 38% YoY to INR 3,091 Cr and EBITDA up 26% to INR 749 Cr, driven primarily by volume-led inpatient and outpatient growth.

Highlights
Revenue growth38% YoY growth in Q1 FY27.
MarginsOperating margin at 24.2%; ex-Sahyadri hospitals at 25%.
Demand visibilityStrong, evidenced by 65% occupancy and 39% IP volume growth.
Management confidenceHigh, citing sustainable volume-led growth and successful greenfield ramp-ups.

Growth

Revenue grew 38%+ YoY; network EBITDA rose 26%+. Inpatient volumes increased 39% while OP volumes rose 26%.

Outlook

Capex of INR 2,000 Cr planned for FY27; adding 1,000 beds. Targeting 3,000 additional beds over 3-4 years.

Risks

One-off pre-acquisition contract benefits in the prior year and greenfield gestation costs impacted margins slightly.

Source

Investor Presentation filed with BSE, NSE: MANIPALHOS. Summary written with AI assistance from the document.

Read the document ↗

Manipal Health Enterprises Ltd: key numbers

Share price
₹674.25
Market cap
₹88,689 Cr
Revenue (annual)
₹10,336 Cr
Net profit (annual)
₹892.3 Cr
Promoter holding
72.08%
FII holding
3.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Manipal Health Enterprises Ltd

All →